Par Pharmaceutical Hit With Securities Suits

Law360 (July 21, 2006, 12:00 AM EDT) -- Drugmaker Par Pharmaceutical Companies, Inc. has been hit with a lawsuit alleging the company misled investors and overstated its revenue by at least $55 million.

The lawsuit, filed in federal court in Manhattan, seeks class action status, and lists the New Jersey-based company, one current executive and one former executive as defendants.

David Rosenfeld, an attorney for the plaintiff, was confident about his client’s prospects, saying Par’s July 5 admission that it had overstated its earnings and would have to restate financial results for 2004, 2005...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.